phase readout
saveNCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
COMPLETEDupdated 9d ago
community read0 votes
Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Alopecia Areata
view source ↗
comments(0)
5-min edit window · permanent after that